Moderna’s COVID-19 mRNA vaccine trial was one of the most diverse clinical trials in history. LaQuinta Jernigan, Executive Vice President for the Americas at mdgroup ...

The drug development landscape for vitiligo is sparse despite its social impact on individuals irrespective of race, ethnicity, or gender. Sometimes dubbed a “cosmeti...

Wearables have the potential to transform healthcare. They can help to inform timely, data-driven interventions. But validating each new digital measure is time-consu...

This past year has seen life sciences companies settle into new operating models and digital ways of working, many of whom have come to realise that a return to the p...

The COVID-19 pandemic created a public health emergency that has had a profound impact on all aspects of the clinical trial industry. Quarantine requirements and limi...

By empowering researchers to detect data quality issues in real-time, Risk-Based Quality Management (RBQM) and Risk-Based Monitoring (RBM) have proven their value dur...

The Malaysian government has continuously strived to improve and expand its clinical research ecosystem for the past ten years. The primary goal is to provide a compe...

Classical drug development is undoubtedly indication- and product-driven. Simply put, a preclinically developed substance is optimised for clinical application in an ...

Pharma Starts its Psychedelic Journey Steffanie Wilson at The Emmes Company affirms that both public and medical opinion is changing quickly and substances that were...

While clinical trials have become lengthy and very costly with low success rates, the application of innovative artificial intelligence (AI)- based approaches has bee...